hVIVO inks influenza trial contract and unveils unified brand as integrated platform strategy takes shape

The AIM-listed clinical development specialist completes its transformation with a new deal and a rebrand consolidating four service lines under one identity. hVIVO PLC (AIM:HVO) has signed a contract to run an influenza human challenge trial for Traws Pharma on the same day it unveiled a new brand identity, marking the completion of its transformation into a fully integrated drug development partner.